Health and Quality of Life Outcomes

Table 2 EQ5D utility score and EQ-VAS score analysis

From: The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study

Time	EQ5D Utility Score
Time	Median	Minimum	Maximum	Z-score	p
Before treatment	0.604	0.098	0.766	−2.703	0.007*
After treatment	0.664	0.393	0.798	−2.703	0.007*
Time	EQ-VAS Score
	Mean (SD)	Difference (SD)	Mean 95% CI		p
	Mean (SD)	Difference (SD)	Lower	Upper	p
Before treatment	65 ± 13.06	6.67 ± 8.75	2.32	11.02	0.005*
After treatment	71.67 ± 15.53	6.67 ± 8.75	2.32	11.02	0.005*

SD standard deviation, EQ5D EuroQoL-5 Dimensions, EQVAS EuroQoL-Visual Analogue Scale, *p < 0.05; 95% CI

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com